Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia
Evidence on long-term effectiveness and cost effectiveness of treatment sequences for multiple myeloma (MM) is sparse. We used published data and country-specific data to assess the cost effectiveness of four-line treatment sequences for elderly transplant-ineligible patients with MM in Serbia.
Saved in:
Main Authors: | Vukićević Đurđa (Author), Rochau Ursula (Author), Savić Aleksandar (Author), Schaffner Monika (Author), Jevđević Milica (Author), Stojkov Igor (Author), Sroczynski Gaby (Author), Willenbacher Wolfgang (Author), Jahn Beate (Author), Siebert Uwe (Author) |
---|---|
Format: | Book |
Published: |
Sciendo,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma
by: Francesca Bonello, et al.
Published: (2020) -
Unravelling Transplant-Ineligible Newly Diagnosed Multiple Myeloma Treatment in Real-World Practice in Spain: The CARINAE Study
by: Felipe de Arriba de la Fuente, et al.
Published: (2024) -
lHCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality
by: Siebert Uwe, et al.
Published: (2009) -
Transcultural nursing in Republic of Serbia: An important factor for health equality
by: Pajić-Nikolić Ljubica, et al.
Published: (2022) -
Risk factors associated with ineligibility of adjuvant cisplatin-based chemotherapy after nephroureterectomy
by: Shao IH, et al.
Published: (2014)